CALI: CalciMedica Inc Sotuvga nisbatan narx
CalciMedica, Inc. (CALI) biofarmatsevtika startapi sifatida faoliyat yuritmoqda va daromad keltirmasdan, barcha kapitalni tadqiqotlarga investitsiya qilmoqda. Savdo hajmining yo'qligi narxning savdoga nisbati koeffitsienti orqali yaqqol namoyon bo'lmoqda, bunda 0.00 darajasi joriy qiymatni tashkil etadi. Geosiyosiy keskinliklar va sanksiyalar biomateriallar logistikasini murakkablashtirmoqda, shunga qaramay, professional boshqaruv yallig'lanishga qarshi dori vositalari sinovlari natijalari asosida kompaniya tuzilmasini muvaffaqiyatli moslashtirmoqda.
CalciMedica, Inc. (CALI) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati CalciMedica, Inc.|CALI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati calcimedica.com|CALI - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar CalciMedica Corp|CALI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari CalciMedica|Shoshilinch likvidlik calcimedica.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CALI - Sof foyda|Sof foyda prognozi CalciMedica, Inc.|CALI - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati calcimedica.com|CALI - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti CalciMedica Corp|CALI - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) CalciMedica|CALI - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi calcimedica.com|CALI - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi CalciMedica, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:CALI, CalciMedica Inc
Ushbu koeffitsient CalciMedica, Inc. (CALI) kompaniyasining bozor qiymatini uning savdo hajmi bilan solishtiradi va aktivning generatsiya qilingan pul oqimiga nisbatan haddan tashqari qimmat baholanganligini baholash imkonini beradi. Yuqori patent kengayuvchanligi bilan tavsiflanadigan biotexnologiya sektori uchun ushbu narx-savdo nisbati terapiyaning global darajada joriy etilishiga bo'lgan bozor kutganlarini aks ettiradi va investorlarga haddan tashqari qimmat baholangan biznesni sotib olish xavfini o'z vaqtida aniqlashga yordam beradi.
CalciMedica, Inc. raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Protagonist Corp (PTGX) - Kapitalizatsiyaning daromadga nisbati|IMVT: P/S multiplikatori|kiniksa.com (KNSA) - P/S multiplikatori|Narxning daromadga nisbati Grifols|Narxning daromadga nisbati ADPT|P/S multiplikatori CLDX|Kapitalizatsiyaning daromadga nisbati Aurinia Corp AUPH|P/S multiplikatori BCRX (BioCryst)|Narx/daromad koeffitsiyenti veratx.com (VERA)|DNTH - Narxning daromadga nisbati|Pharvaris NV (PHVS) - Kapitalizatsiyaning daromadga nisbati|ABCL: P/S multiplikatori|Sotuvga nisbatan narx Tourmaline (TRML)|PGEN (Precigen, Inc.) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PHAR (pharming.com)|P/S multiplikatori NKTR|Narx/daromad koeffitsiyenti Upstream Bio, Inc.|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|IMNM - Kapitalizatsiyaning daromadga nisbati|Gossamer Bio, Inc. - P/S multiplikatori|KALV - P/S multiplikatori|SEPN (Septerna) - Kapitalizatsiyaning daromadga nisbati|Pieris Pharma - Bozor kapitallashuvining daromadga nisbati|SVRA (Savara Corp) - P/S multiplikatori|Rigel Corp (RIGL) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati AnaptysBio, Inc. (ANAB)|astriatx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ENGN (enGene)|RAPT - Kapitalizatsiyaning daromadga nisbati|JBIO: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Aclaris Therapeutics, Inc ACRS|KYTX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati tizianalifesciences.com|CABA (Cabaletta Bio) - P/S multiplikatori|P/S multiplikatori Ventyx Biosciences Inc.|Narxning daromadga nisbati Theratechnologies Inc (THTX)|Narxning daromadga nisbati AVTX (Avalo Therapeutics Inc)|P/S multiplikatori ELDN (Eledon Pharmaceuticals)|Narx/daromad koeffitsiyenti agenusbio.com (AGEN)|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ZURA|ATYR: P/S multiplikatori|Adagene Inc. - Bozor kapitallashuvining daromadga nisbati|IMA (ImageneBio) - P/S multiplikatori|P/S multiplikatori Shattuck Therapeutics|Narxning daromadga nisbati Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Immunic IMUX|ATRA - Kapitalizatsiyaning daromadga nisbati|InflaRx GmbH - P/S multiplikatori|XFOR - P/S multiplikatori|ACET (adicetbio.com) - Kapitalizatsiyaning daromadga nisbati|Celularity - Bozor kapitallashuvining daromadga nisbati|INMB (INmune Bio Corp) - P/S multiplikatori|Barinthus Biotherapeutics Corp (BRNS) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Kezar Life Sciences (KZR)|Kapitalizatsiyaning daromadga nisbati sabbiotherapeutics.com SABS|Narxning daromadga nisbati Akari Therapeutics Plc AKTX|ENLV - Kapitalizatsiyaning daromadga nisbati|QTTB: Kapitalizatsiyaning daromadga nisbati|GOVX - P/S multiplikatori|Edesa Biotech, Inc. (EDSA) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati IBIO|CARM (Carisma Therapeutics Inc) - P/S multiplikatori|Sotuvga nisbatan narx XTL Biopharmaceuticals Ltd XTLB|P/S multiplikatori BOLT|Kapitalizatsiyaning daromadga nisbati hcwbiologics.com HCWB|P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|P/S multiplikatori AIM ImmunoTech, Inc. AIM|ADTX - Narxning daromadga nisbati|GRI: Narxning daromadga nisbati|XRTX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Vyome Therapeutics|REVB (Revelation Biosciences) - P/S multiplikatori|indaptusrx.com (INDP) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|Kapitalizatsiyaning daromadga nisbati affimed.com AFMD|P/S multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - Sotuvga nisbatan narx|IGM Bio - P/S multiplikatori|ITOS (iteostherapeutics.com) - Kapitalizatsiya va daromad nisbati|OCEA: P/S multiplikatori|TCBP - Narx/daromad koeffitsiyenti|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
